Jenburkt Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030
Updated on 05/03/2024
Stock Rating
0
Price Target
Rp0.00
Consensus
-
Downside
-100.00%
Analysts
0
Stock Rating
0
Downside
-100.00%
Analysts
0
Price Target
Rp0.00
Jenburkt Pharmaceuticals Stock Forecast and Price Target
Jenburkt Pharmaceuticals's most recent price target of Rp0.00 for 2024 was provided by renowned analysts over the past few months, with an average prediction of Rp0.00. If this prediction is correct, Jenburkt Pharmaceuticals's stock could fall by -,100 percent from its current trading price. The potential decrease for the stock is Rp0.00 per share, with a possible range of Rp0.00 to Rp0.00. Even if you are not interested in 524731 stock, it is still imperative to be aware of its competitors.
Rp0.00
N/A
-
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AJANTPHARM Stock Forecast | Ajanta Pharma | Outperform |
18
|
Rp2.38k | Buy/Sell | Rp1.95k | -0.27% |
| LAURUSLABS Stock Forecast | Laurus Labs | Hold |
18
|
Rp447.35 | Buy/Sell | Rp370.83 | -16.17% |
| ZOTA Stock Forecast | Zota Health Care | - |
16
|
Rp488.40 | Buy/Sell | Rp0.00 | -100.00% |
| SAKAR Stock Forecast | Sakar Healthcare | - |
0
|
Rp348.40 | Buy/Sell | Rp0.00 | -100.00% |
| 542248 Stock Forecast | Deccan Health Care | - |
0
|
Rp25.87 | Buy/Sell | Rp0.00 | -100.00% |
.jpg)
Site Navigation
.jpg)